# Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina

Study · id `cardio:ct-nct05711849` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05711849](<https://clinicaltrials.gov/study/NCT05711849>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05711849

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 110 participants.

## Technical summary

Registry record NCT05711849. Randomized; double masking; primary purpose treatment. Start 2024-03-01 (actual); primary completion 2026-08-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 110 participants (planned count; ClinicalTrials.gov record NCT05711849, source copy `cardio:ctgov-nct05711849-2026-01-07`, retrieved 2026-11-18)
- Started: 2024-03-01 (actual) (ClinicalTrials.gov record NCT05711849, source copy `cardio:ctgov-nct05711849-2026-01-07`, retrieved 2026-11-18)
- Primary completion: 2026-08-31 (anticipated) (ClinicalTrials.gov record NCT05711849, source copy `cardio:ctgov-nct05711849-2026-01-07`, retrieved 2026-11-18)
- Completion: 2026-08-31 (anticipated) (ClinicalTrials.gov record NCT05711849, source copy `cardio:ctgov-nct05711849-2026-01-07`, retrieved 2026-11-18)
- Countries: United Kingdom (ClinicalTrials.gov record NCT05711849, source copy `cardio:ctgov-nct05711849-2026-01-07`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05711849-2026-01-07`, retrieved 2026-11-18)

## The registry's words

- Brief title: Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina
- Acronym: RegenCobra
- Condition: Refractory Angina Pectoris
- Condition: Refractory Angina
- Intervention (Biological): Bone marrow aspiration and a single intracoronary infusion of autologous bone marrow-derived mononuclear cells.
- Intervention (Procedure): Sham bone marrow aspiration and sham cell infusion (insertion of vascular access sheath).
- Lead sponsor: Barts & The London NHS Trust
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Angina pectoris (`cardio:angina-pectoris`)
- Registry lists this organization as the lead sponsor: Barts & The London NHS Trust (`cardio:org-barts-the-london-nhs-trust`)

## Provenance

Content hash: 78caefd7ef01fcc9af29856cd138861b90f0c247ef2dc72df31445384f8a5578
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
